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A B S T R A C T
Eighty-four children with mental retardation
(34 boys, 50 girls; age range 2–18 years, median
6 years) and 84 age- and gender-matched outpa-
tient controls were studied. All children were
living at home, had never stayed in an institution,
and came from the same urban area. Seropositiv-
ity for Helicobacter pylori was found in 42 (50%) of
84 mentally retarded children and 16 (19%) of
84 controls (p < 0.01). Socio-economic factors did
not differ between the two groups. The findings
indicated that a higher prevalence of H. pylori
Corresponding author and reprint requests: P. Strisciuglio,
Dipartimento di Medicina Sperimentale e Clinica, Cattedra di
Pediatria, Via T Campanella 115, 88100 Catanzaro, Italy
E-mail: strisciuglio.unicz@libero.it
670 Clinical Microbiology and Infection, Volume 10 Number 7, July 2004
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 657–678
infection occurs in children with mental retarda-
tion, regardless of whether they are institutional-
ised.
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Clinical and epidemiological data indicate that
Helicobacter pylori is generally acquired during
childhood [1] or early infancy [2], and probably
remains for the lifetime of the host [3]. Poor socio-
economic conditions and overcrowding during
childhood are major risk factors for acquisition
[4,5]. As humans are considered to be the sole
natural hosts of H. pylori, this suggests that person-
to-person contact plays a key role in transmission.
Physically and mentally disabled children may be
particularly exposed to microorganisms because of
different feeding abilities, toilet needs, and living
and sanitary arrangements, and a higher frequency
of H. pylori infection has been shown among
institutionalised children with mental retardation
(MR) [6–10]. Since institutionalised healthy sub-
jects also display a higher prevalence of H. pylori
infection [11,12], the present study investigated the
seroprevalence of H. pylori infection among non-
institutionalised children with MR.
Eighty-four non-institutionalised children (34
boys, 50 girls; age range 2–18 years, median
6 years) with MR and 84 age-matched (± 1 years)
and gender-matched outpatient controls were
included in the study. None of the children had
lived previously in an institution, or taken antibi-
otics or non-steroidal anti-inflammatory drugs in
the previous 6 months. The children were recrui-
ted consecutively in the Paediatric Unit of the
Department of Clinical and Experimental Medi-
cine at Catanzaro University between January and
December 2000. Children with MR came from a
group of 300 children who are regularly (every
6–12 months) followed in the MR Paediatric
subunit. The control group attended the general
Paediatric Unit weekly during the recruitment
period.
All children were from the same urban area
(Catanzaro Province, southern Italy). In children
with MR, the following diagnoses were made:
Down’s syndrome (50%; n = 42); chromosome
abnormalities (12%; n = 10); recognisable syn-
dromes (16.5%; n = 14); structural central nervous
system abnormalities (2.5%; n = 2); metabolic
causes (2.5%; n = 2); and unknown causes
(16.5%; n = 14). A small proportion of children
with MR (9.5%; n = 8) had dyspeptic symptoms
(i.e., early satiety, abdominal fullness, post-pran-
dial epigastric abdominal pain). Children with
MR were either an only child (24%), the
first child (33%), the second child (20%), the third
child (12%), the fourth child (7%), or the fifth child
(4%). All children had regular social contact with
other children at school and in rehabilitation
centres (physiotherapy and occupational therapy).
Clinical manifestations in outpatient controls
were as follows: failure to thrive (21%; n = 18);
recurrent abdominal pain (19%; n = 16); iron
deficiency anaemia (14%; n = 12); anorexia
(12%; n = 10); asthma (9%; n = 8); vomiting
(7%; n = 6); dermatitis (7%; n = 6); viral gastro-
enteritis (5%; n = 4); cytomegalovirus infection
(2%; n = 2); and constipation (2%; n = 2).
Formal testing for mental impairment was
performed using the Brunet–Lezine [13] and
Terman–Merrill [14] tests. No child had under-
gone anti-H. pylori therapy previously. Informed
parental consent was obtained for all procedures
in the study. The study was approved by the
University Ethical Committee.
All children and parents were interviewed by
means of a structured questionnaire dealing with
a number of socio-economic factors. The occupa-
tion of the parents was classified as manual or
non-manual, and the length of their education
was recorded. The social class of each child was
grouped into three categories (low, middle and
high) according to the annual household income.
The number of siblings sharing a bed or bedroom,
and the ratio of the number of persons to the
number of rooms (excluding kitchen and bath-
room), were considered separately as a quantita-
tive index of housing density. Possession of a
bathroom and indoor toilet was recorded. The
same interviewer (EP) administered all the ques-
tionnaires.
Serum immunoglobulins (IgG) produced in
response to H. pylori infection were measured
with the Helori-test IgG (Eurospital, Trieste,
Italy), validated locally in a paediatric setting
(92% sensitivity, 91% specificity) [15]. A sub-
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group of 20 children with MR also underwent
13C-urea breath tests (UBT; Cortex, Milan, Italy).
Differences between groups were compared by
Student’s t-test, v2 test or Mantel–Haenszel v2 test,
as appropriate.
Seropositivity for H. pylori was significantly
higher in children with MR than in the controls
(42 ⁄ 84 vs. 16 ⁄ 84; p < 0.01). Socio-economic fea-
tures did not differ between the two groups
(Table 1). The degree of MR was mild in 32 child-
ren (38%), moderate in 26 (31%), and severe in 26
(31%). Seropositivity for H. pylori did not differ
according to the degree of mental impairment.
There was 95% concordance between 13C-UBT
and H. pylori serology (ten H. pylori-positive and
nine H. pylori-negative by both tests; one serology-
positive and 13C-UBT-negative) in the subgroup
of 20 children with MR who underwent both
procedures.
The study demonstrated that non-institutional-
ised urban children with MR have a high sero-
prevalence (50%) of H. pylori infection. A similar
high frequency of H. pylori infection among insti-
tutionalised children with neurological impair-
ment has been described previously [6–10]. In
particular, in a very small series, the incidence [7]
and prevalence [10] of H. pylori were significantly
higher in institutionalised than in non-institution-
alised children. However, since mentally disabled
children in the present study were living at home
and had not stayed in an institution, the high
seroprevalence of H. pylori infection cannot be
explained by institutionalisation alone.
Despite worldwide spread of H. pylori infec-
tion, the exact route of transmission remains
controversial. Even though person-to-person
spread is considered most likely, confirmatory
epidemiological evidence for faecal–oral and oral–
oral routes of transmission is absent. Assuming
that H. pylori colonises only the human gastric
mucosa, it has been postulated that gastro-oral
transmission may occur, and that this may be a
likely route of spread during epidemic vomiting or
regurgitation in children [16,17]. This hypothesis
has been supported by experimental [18–20] and
clinical data [21]. Poor personal hygiene may
account for an increased risk of H. pylori infection
in mentally disabled children, possibly following
chronic gastric regurgitation or frequent vomiting
by infected cohabiting children, either within or
outside the family (e.g., at day care centres or
kindergarten). If mental retardation of any degree
affects the risk of acquiring H. pylori infection, this
may explain the lack of correlation between
seroprevalence of H. pylori and the severity of
mental impairment.
Poor socio-economic conditions during child-
hood constitute a major risk factor for H. pylori
infection [4,5]. The control population was from
the same geographical area as the study group
and had comparable socio-economic features. The
occupation of a child’s father and his level of
education was mostly (> 90%) the highest in the
family, so this was considered representative of a
family’s status. In addition, the mother’s occupa-
tion and level of education did not differ between
children with MR and controls (data not shown).
These considerations strengthen the validity of
comparisons with respect to the seroprevalence of
H. pylori infection among the study population
and controls. Some clinical symptoms in the
control population have been associated with
H. pylori infection (e.g., recurrent abdominal pain
and iron deficiency anaemia), leading to the
possibility that the statistical significance of the
study results might be even greater. However,
overall, the findings of the study indicated that
H. pylori infection occurs at a higher rate in
children with MR, independently of institution-
alisation. This may provide clues to understand-
ing and controlling the transmission of H. pylori.
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A B S T R A C T
In order to investigate the impact of Pneumocystis
carinii infection in southern Spain following the
introduction of highly active anti-retroviral ther-
apy (HAART), all cases of pneumocystosis be-
tween 1998 and 1999 were identified from data
compiled by the national surveillance system. In
total, 498 cases of pneumocystosis were recorded,
of which 87% involved HIV-positive patients. The
mean age, length of hospital stay and mortality
were higher for HIV-negative patients. There
was a higher number of cases in winter. Des-
pite HAART implementation, pneumocystosis
remains a significant health problem for both
HIV-positive and HIV-negative patients.
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